Concepedia

Robert Ryall

RR

15

Publications

1.5K

Citations

14

H-Index

2000

Active since

Affiliations

University of Maryland, Baltimore(Current)

Sanofi (United States)

University of Cape Town

Centre de Recherche Médicale et Sanitaire

Statens Serum Institut

Robert Ryall is an author at University of Maryland, Baltimore specializing in medicine, immunology, and vaccination.

Top concepts

Publications per year

2000–2018

15

Publications

15

Prevention of <i>M. tuberculosis</i> Infection with H4:IC31 Vaccine or BCG Revaccination

Elisa Nemes, Hennie Geldenhuys, Virginie Rozot et al. · New England Journal of Medicine · 2018 · 650 citations · Full text

Safety, Immunogenicity, and Immune Memory of a Novel Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MCV-4) in Healthy Adolescents

Harry Keyserling, Thomas Papa, Katalin Koranyi et al. · Archives of Pediatrics and Adolescent Medicine · 2005 · 153 citations

Comparative Trial of the Safety and Immunogenicity of Quadrivalent (A, C, Y, W-135) Meningococcal Polysaccharide-Diphtheria Conjugate Vaccine Versus Quadrivalent Polysaccharide Vaccine in Two- to Ten-Year-Old Children

Michael E. Pichichero, Janet R. Casey, Mark M. Blatter et al. · The Pediatric Infectious Disease Journal · 2005 · 120 citations

Dosage Escalation, Safety and Immunogenicity Study of Four Dosages of a Tetravalent Meninogococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Infants

Margaret B. Rennels, James C. King, Robert Ryall et al. · The Pediatric Infectious Disease Journal · 2004 · 118 citations

Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger

G Campagne, Amadou Garba, Pascal Fabre et al. · The Pediatric Infectious Disease Journal · 2000 · 103 citations

Rows per page

1–5 of 15